Professor Pujitha Wickramasinghe
Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled,phase 3 trial.
Ultimate control of dengue infection lies on the availability of a reliable vaccine. This paper discuss the efficacy of a dengue vaccine that is being field tested currently which has gvien some promising results.